CTLA-4 ligation blocks CD28-dependent T cell activation.
Theresa L. Walunas, Christina Y. Bakker, Jeffrey A. Bluestone · The Journal of Experimental Medicine · 1996
CTLA-4 is a CD28 homologue believed to be a negative regulator of T cell function. However, the mechanism of this downregulatory activity is not well understood. The present study was designed to examine the effect of CTLA-4 ligation on cytokine production, cell survival, and cell cycle progression. The results demonstrate that the primary effect of CTLA-4 ligation is not the induction of apoptosis. Instead, CTLA-4 signaling blocks IL-2 production, IL-2 receptor expression, and cell cycle progression of activated T cells. Moreover, the effect of CTLA-4 signaling was manifested after initial T cell activation. Inhibition of IL-2 receptor expression and cell cycle progression was more pronounced at late (72 h) time points after initial activation. The effects of anti-CTLA-4 mAbs were most apparent in the presence of optimal CD28-mediated costimulation consistent with the finding that CTLA-4 upregulation was CD28-dependent. Finally, the addition of exogenous IL-2 to the cultures restored IL-2 receptor expression and T cell proliferation. These results suggest that CTLA-4 signaling does not regulate cell survival or responsiveness to IL-2, but does inhibit CD28-dependent IL-2 production.
Cited by 801 works. doi:10.1084/jem.183.6.2541 Open-access PDF
Authors
References
- Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
- Identification of a monoclonal antibody specific for a murine T3 polypeptide.
- Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
- Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
- CTLA-4 is a second receptor for the B cell activation antigen B7.
- CTLA-4 can function as a negative regulator of T cell activation
- Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.
- Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors.
- IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement.
- CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.